Increased galectin-3 expression in human brain samples has been documented in the pathology of different neurodegenerative diseases including Alzheimer’s disease (AD) [21, 22] and Huntington’s disease (HD) [23]. This evidence concerns the gene LGALS3 and Huntington disease.